Recent Developments in 14-3-3 Stabilizers for Regulating Protein-Protein Interactions: An Update.

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Therapeutics

Background:

• 14-3-3 proteins are critical regulators of protein-protein interactions involved in numerous cellular processes.
• Dysregulation of 14-3-3 protein interactions is implicated in various diseases, including cancer, metabolic disorders, and neurodegenerative conditions.
• Small molecule stabilizers that enhance 14-3-3 protein binding to client proteins represent a promising therapeutic strategy.

Purpose of the Study:

• To provide an updated overview of recent advancements in 14-3-3 stabilizers.
• To discuss the design, synthesis, and biological evaluation of these compounds.
• To highlight the therapeutic potential of 14-3-3 stabilizers in major disease areas.

Main Methods:

• Review of recent scientific literature on 14-3-3 stabilizers.
• Analysis of structural data regarding 14-3-3 protein-ligand interactions.
• Exploration of therapeutic applications and ongoing research.

Main Results:

• Recent developments in 14-3-3 stabilizers focus on enhancing binding affinity and selectivity.
• Key structural modifications have been identified to improve stabilizer efficacy.
• Promising therapeutic applications are emerging in oncology, metabolic diseases, and neurology.

Conclusions:

• 14-3-3 stabilizers represent a rapidly advancing field with significant therapeutic promise.
• Further optimization of these compounds is crucial for their clinical translation.
• Future research should focus on refining stabilizer design and expanding their therapeutic utility.